[HTML][HTML] Pathological angiogenesis: mechanisms and therapeutic strategies

AC Dudley, AW Griffioen - Angiogenesis, 2023 - Springer
In multicellular organisms, angiogenesis, the formation of new blood vessels from pre-
existing ones, is an essential process for growth and development. Different mechanisms …

[HTML][HTML] Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

MJ Ansari, D Bokov, A Markov, AT Jalil… - Cell Communication and …, 2022 - Springer
Abnormal vasculature is one of the most conspicuous traits of tumor tissue, largely
contributing to tumor immune evasion. The deregulation mainly arises from the potentiated …

[HTML][HTML] Consensus guidelines for the use and interpretation of angiogenesis assays

P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov… - Angiogenesis, 2018 - Springer
The formation of new blood vessels, or angiogenesis, is a complex process that plays
important roles in growth and development, tissue and organ regeneration, as well as …

[HTML][HTML] Accessories to the crime: functions of cells recruited to the tumor microenvironment

D Hanahan, LM Coussens - Cancer cell, 2012 - cell.com
Mutationally corrupted cancer (stem) cells are the driving force of tumor development and
progression. Yet, these transformed cells cannot do it alone. Assemblages of ostensibly …

Hypoxia-induced angiogenesis: good and evil

BL Krock, N Skuli, MC Simon - Genes & cancer, 2011 - journals.sagepub.com
The vascular network delivers oxygen (O2) and nutrients to all cells within the body. It is
therefore not surprising that O2 availability serves as a primary regulator of this complex …

[HTML][HTML] Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

H Mehta, A Tufail, V Daien, AY Lee, V Nguyen… - Progress in retinal and …, 2018 - Elsevier
Clinical trials identified intravitreal vascular endothelial growth factor inhibitors (anti-VEGF
agents) have the potential to stabilise or even improve visual acuity outcomes in …

[HTML][HTML] A systematic review of miR-29 in cancer

JJ Kwon, TD Factora, S Dey, J Kota - Molecular Therapy-Oncolytics, 2019 - cell.com
MicroRNAs (miRNA) are small non-coding RNAs (∼ 22 nt in length) that are known as
potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a …

[HTML][HTML] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

D Hanahan, J Folkman - cell, 1996 - cell.com
Introduction confirmed this result and further revealed that in the Blood vessels are
fundamentally composed of endotheabsence of access to an adequate vasculature, tumor …

[HTML][HTML] Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

MS O'Reilly, T Boehm, Y Shing, N Fukai, G Vasios… - cell, 1997 - cell.com
We previously identified the angiogenesis inhibitor angiostatin. Using a similar strategy, we
have identified endostatin, an angiogenesis inhibitor produced by hemangioendothelioma …

Angiogenesis in cancer

N Nishida, H Yano, T Nishida, T Kamura… - Vascular health and …, 2006 - Taylor & Francis
New growth in the vascular network is important since the proliferation, as well as metastatic
spread, of cancer cells depends on an adequate supply of oxygen and nutrients and the …